Literature DB >> 19236278

Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.

Rolando Herrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19236278     DOI： 10.1086/597308

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  33 in total

Review 1.  Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

Authors:  M Blomberg; S Y He; C Harwood; S T Arron; S Demehri; A Green; M M Asgari
Journal:  Br J Dermatol       Date:  2017-10-30       Impact factor: 9.302

2.  Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial.

Authors:  Staci L Sudenga; B Nelson Torres; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim Van der Loeff; Louvina E Van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano
Journal:  J Infect       Date:  2015-10-19       Impact factor: 6.072

Review 3.  Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.

Authors:  Daniel C Beachler; Gwendolyne Jenkins; Mahboobeh Safaeian; Aimée R Kreimer; Nicolas Wentzensen
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

4.  Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.

Authors:  Kirill Kalnin; Timothy Tibbitts; Yanhua Yan; Svetlana Stegalkina; Lihua Shen; Victor Costa; Robert Sabharwal; Stephen F Anderson; Patricia M Day; Neil Christensen; John T Schiller; Subhashini Jagu; Richard B S Roden; Jeffrey Almond; Harold Kleanthous
Journal:  Vaccine       Date:  2014-04-26       Impact factor: 3.641

5.  Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Allan Hildesheim; Ana Cecilia Rodríguez; Wim Quint; Mark Schiffman; Leen-Jan Van Doorn; Carolina Porras; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Rolando Herrero
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

Review 6.  Cervical Cancer Screening.

Authors:  George F Sawaya; Megan J Huchko
Journal:  Med Clin North Am       Date:  2017-04-21       Impact factor: 5.456

7.  Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Authors:  Jing Ye; Xiaodong Cheng; Xiaojing Chen; Feng Ye; Weiguo Lü; Xing Xie
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

8.  Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Sholom Wacholder; Ana C Rodríguez; Diane Solomon; Paula González; Aimee R Kreimer; Carolina Porras; John Schussler; Silvia Jiménez; Mark E Sherman; Wim Quint; John T Schiller; Douglas R Lowy; Mark Schiffman; Allan Hildesheim
Journal:  Cancer Discov       Date:  2011-09-09       Impact factor: 39.397

9.  Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.

Authors:  Ariana Harari; Zigui Chen; Ana Cecilia Rodríguez; Allan Hildesheim; Carolina Porras; Rolando Herrero; Sholom Wacholder; Orestis A Panagiotou; Brian Befano; Robert D Burk; Mark Schiffman
Journal:  J Infect Dis       Date:  2015-10-30       Impact factor: 5.226

10.  Potential benefits of second-generation human papillomavirus vaccines.

Authors:  Sorapop Kiatpongsan; Nicole Gastineau Campos; Jane J Kim
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.